Search
Browse
Statistics
Feeds

Fragment-based covalent targeting of lysines at the allosteric latch site of SHP2

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
13MB
[thumbnail of Supporting Information] Other (Supporting Information)
10MB

Item Type:Article
Title:Fragment-based covalent targeting of lysines at the allosteric latch site of SHP2
Creators: Di Lorenzo, Vincenzo ORCID logoORCID: https://orcid.org/0000-0002-3140-3561, Csorba, Noémi, Szabó, Renáta, Kollár, Levente ORCID logoORCID: https://orcid.org/0000-0001-9679-3735, Roske, Yvette ORCID logoORCID: https://orcid.org/0000-0001-6237-388X, Rand̵elović, Ivan, Balázs, Krisztina, Szalai, Tibor Viktor ORCID logoORCID: https://orcid.org/0009-0000-4088-3117, Efrém, Nina-Louisa ORCID logoORCID: https://orcid.org/0009-0000-6505-4120, Mihalovits, Levente, Imre, Tímea, Simon, József, Tóvári, József, Nazaré, Marc ORCID logoORCID: https://orcid.org/0000-0002-1602-2330, Daumke, Oliver ORCID logoORCID: https://orcid.org/0000-0002-6190-1414, Ábrányi-Balogh, Péter ORCID logoORCID: https://orcid.org/0000-0002-9284-5160 and Keserű, György M. ORCID logoORCID: https://orcid.org/0000-0003-1039-7809
Abstract:Covalent mechanism of action is a powerful way to modulate challenging drug targets. Here, we present a streamlined workflow that combines covalent fragment screening (electrophile first approach) and ligand-first strategy to identify covalent inhibitors targeting lysine residues in the allosteric latch site of SHP2 phosphatase. Supported by complementary computational and experimental analyses, this strategy enabled us to identify the first potent cell active allosteric covalent inhibitors acting at this site. Demonstrating the covalent tractability of the latch site opens further avenues for future optimization and therapeutic exploration of high-value allosteric SHP2 inhibitors.
Keywords:SHP2 Phosphatase, Covalent Inhibitor, Allosteric Modulator, Lysine Labelling, NHS-Ester, Dichlorotriazine, X-Ray Structure
Source:Journal of Medicinal Chemistry
ISSN:0022-2623
Publisher:American Chemical Society
Volume:69
Number:19
Page Range:21955-21971
Number of Pages:17
Date:8 October 2026
Official Publication:https://doi.org/10.1021/acs.jmedchem.6c01030
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library